FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/19/2026
Back to search
Official data from USPTO
DERMATOPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079377981Class
1, 5, 10, 42, 44
Filing
79377981
Registration
7894983
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 10, 42, 44
Filing date
07/31/2023
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
AU
Examiner
VENGURLEKAR, SAGAR S
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "DERMATOPLEX".
Holders and representatives
Holders
SpeeDx Pty Ltd
Representatives
Jefferson F. Scher Carr & Ferrell LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplificationanalysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogensinfectionsinfectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acidsnucleic recombinant acids to identify pathogensinfectionsinfectious diseases for scientific purposes; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients
Class 5
Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogensinfectionsinfectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceuticalveterinary and medical purposes; enzyme preparations for pharmaceuticalveterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionto diagnose and identify pathogensinfectionsinfectious diseases; diagnostic kits comprising diagnostic agentspreparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disordersall for testing of bodily fluids for use in disease detectionto diagnose and identify pathogensinfectionsinfectious diseases; none of the foregoing for use in or as a medicated shampoo
Class 10
Surgicalmedical and veterinary apparatus and instruments for diagnosis of diseasefor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy for treatment of infectious diseasesimmunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposesfor diagnosis of diseasefor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy for treatment of infectious diseasesimmunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of diseasefor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy for treatment of infectious diseasesimmunological diseases and autoimmune diseases; point of care medical devicesa device for testing for diagnosis of diseasefor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy for treatment of infectious diseasesimmunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slidescentrifuge tubesformalin jarscoplin jarsinsert to hold slides and jarsabsorbent clothprinted instructionsall for medical use
Class 42
Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation servicesfor scientific research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experimentsthe results of scientific and medical experiments and teststhe analysis and evaluation of scientific and medical datadata generated by scientific and medical experiments and tests; scientific and medical research and development servicesfor scientific research purposes; custom design and development of biochemical assays
Class 44
Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2026
FIMP
FINAL DISPOSITION PROCESSED
02/26/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/11/2025
GNFR
FINAL REFUSAL E-MAILED
02/11/2025
CNFR
FINAL REFUSAL WRITTEN
02/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/09/2025
DOCK
ASSIGNED TO EXAMINER
01/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/22/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/22/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/22/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/22/2024
ATRV
ATTORNEY REVIEW COMPLETED
08/12/2024
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
07/07/2024
RFNT
REFUSAL PROCESSED BY IB
05/13/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/24/2024
RFRR
REFUSAL PROCESSED BY MPU
04/23/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/04/2024
CNRT
NON-FINAL ACTION WRITTEN
04/03/2024
DOCK
ASSIGNED TO EXAMINER
04/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2023
Continuous trademark protection
Get notified about every new filing that threatens DERMATOPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.